Menu
respiratory

Chronic Beryllium Disease (CBD)

ICD-10 Code
J63.2

Clinical Criteria for Chronic Beryllium Disease (CBD).

Clinical Presentation & Protocol

Patient Usually Complains Of

Patient presents for evaluation of chronic respiratory symptoms in the context of documented occupational beryllium exposure. Reports progressive exertional dyspnea, non-productive cough, and occasional pleuritic chest pain. History of beryllium sensitization confirmed via BeLPT. No history of smoking. Symptoms are insidious in onset and have worsened over [Number] months/years. Denies constitutional symptoms such as night sweats or significant weight loss.

Clinical Examination Findings

General: Patient is in no acute distress, resting comfortably on room air. Respiratory: Lungs are clear to auscultation bilaterally, though fine bibasilar inspiratory crackles are noted. No wheezing or rhonchi. Cardiac: Regular rate and rhythm, S1/S2 normal, no murmurs, rubs, or gallops. Extremities: No clubbing, cyanosis, or peripheral edema. Skin: No evidence of granulomatous skin lesions or sarcoid-like manifestations.

Treatment Protocol

Treatment plan: Initiate systemic corticosteroid therapy with [Drug Name, e.g., Prednisone] at [Dosage] mg daily, with a planned slow taper based on clinical response and PFT improvement. Consider steroid-sparing agents such as [e.g., Methotrexate or Mycophenolate Mofetil] if refractory to steroids. Supplemental oxygen therapy as needed to maintain SpO2 >90% during exertion. Regular monitoring of pulmonary function tests (PFTs), DLCO, and chest imaging. Strict avoidance of further beryllium exposure is mandatory.

Detailed clinical guide coming soon.